Download free PDF

Southeast Asia (SEA) Thoracolumbar Spinal Fusion Implants Market – By Product Type, By Material, By Surgery Type, By Indication, By End Use – Forecast, 2025 - 2034

Report ID: GMI14367
   |
Published Date: July 2025
 | 
Report Format: PDF

Download Free PDF

Southeast Asia Thoracolumbar Spinal Fusion Implants Market Size

The Southeast Asia thoracolumbar spinal fusion implants market was valued at USD 61 million in 2024. The market is anticipated to grow from USD 63.4 million in 2025 to USD 93.4 million in 2034, growing at a CAGR of 4.4% from 2025 to 2034. High market growth is primarily attributed to growing medical tourism in the region, technological advancements in implants and materials, and rising prevalence of spinal diseases among other factors.

Southeast Asia Thoracolumbar Spinal Fusion Implants Market

Rise in number of trauma cases due to road fatalities, surging cases of spinal disorders, and growing awareness towards availability of improved minimally invasive treatment options are anticipated to fuel the product demand. For instance, according to the statistic reported by World Health Organization (WHO), in 2021, Thailand recorded around 25.7 deaths per 100,000 people due to traffic fatalities which is significantly higher in comparison to the global average of around 15 deaths. Thus, the growing burden of road accidents plays a key role in the overall population suffering from various spinal cord injuries.
 

The rise in spinal disorders such as degenerative disc disease, herniated discs, spinal stenosis, spondylolisthesis and traumatic fractures remains a key driver of the regional market. As the percentage of elderly population surges across Thailand, Vietnam and other countries, age-related spine degeneration is expected to witness growth with increasing frequency.
 

Further, the number of certified orthopedic and neurosurgeons trained in the developed countries including U.S., Europe or Australia has grown significantly in the regional countries. Their presence has elevated the skill, safety and accessibility of thoracolumbar spinal fusion procedures, thereby strengthening patient confidence and product uptake.
 

Thoracolumbar spinal-fusion implants are purpose-built tools that lock together the mid-back and lower-back sections of the spine. These devices are used during range of spinal indications including spinal deformity, trauma and degenerative disc diseases.
 

Southeast Asia Thoracolumbar Spinal Fusion Implants Market Trends

  • Growing medical tourism, technological advancements in implant materials, and preference for minimally invasive procedures are among the key industry trends.
     
  • Countries in the region such as Thailand, Malaysia, and Singapore have a significantly higher rank as the hubs for medical tourism, attracting patients who prefer elective procedures such as spinal fusion. These Southeast Asian nations combine surgical expertise with affordable cost structures that remain considerably lower than those found in the U.S. or Europe. A notable portion of the incoming patients come from the Middle East, and other neighboring Asian countries, fueling the need for sophisticated spinal devices, particularly thoracolumbar fusion systems.
     
  • Moreover, the device manufacturers have a keen focus on launching thoracolumbar implants designed from biocompatible, radiolucent materials such as polyether-ether-ketone (PEEK) and advanced titanium alloys. These advanced products have a better adoption rate by spinal surgeons owing to the product features.
     
  • Furthermore, healthcare facilities that are on tighter budgets are shifting many spinal fusion procedures to outpatient settings and ambulatory surgical centers, particularly for minimally invasive thoracolumbar category. This is further supported by growing patient awareness, preference for MIS techniques and the need for faster post procedural recovery.
     

Southeast Asia Thoracolumbar Spinal Fusion Implants Market Analysis


In 2021, the market was valued at USD 54.3 million. The following year, it saw a slight increase to USD 56.4 million, and by 2023, the market further climbed to USD 58.7 million. Based on product type, the market is segmented into pedicle screws, intervertebral body fusion device (IBFD), rods, plates, and other product types. The pedicle screws segment accounted for the leading market share and was valued at USD 24.8 million in 2024.
 

  • The pedicle screw segment accounts for the largest share of the thoracolumbar spinal fusion implant market, as these devices provide the essential three-dimensional stability required during spinal fusion. Surgeons commonly use them to stabilize fractures, correct deformities, remove tumors, or alleviate pressure caused by degenerative disc disease particularly in the thoracolumbar region, where strong fixation is crucial.
     
  • In addition, demand for pedicle screws is rising steadily, driven by their proven ability to stabilize spinal constructions in complex-trauma, degenerative, and deformity cases.
     
  • Further, surgeon familiarity, supportive reimbursement policies, and broader access to spine care in Southeast Asian countries are driving faster adoption across those markets. The aforementioned pointers coupled with increased surgical volumes, advancements in materials among others are anticipated to record healthy growth over the analysis period.
     

Based on material, the Southeast Asia thoracolumbar spinal fusion implants market is categorized into titanium, polyetheretherketone (PEEK), cobalt chrome, stainless steel, and other materials. The titanium segment accounted for leading share in the market in 2024 and is expected to reach around USD 38.3 million in 2034.
 

  • The demand for titanium implants is rising substantially, fueled by its outstanding mechanical properties, remarkable resistance to corrosion, and high compatibility with living tissues. Orthopedic surgeons favor titanium and its alloys, as the material combines light weight with exceptional strength, thereby improving the stability and durability of implant.
     
  • In addition, titanium’s modulus of elasticity is closer to that of human cortical bone than stainless steel, reducing the risk of stress shielding and adjacent segment disease.
     
  • Additionally, the rise in complex and revision spinal procedures has reinforced the demand for titanium, given its superior fatigue strength and compatibility with imaging modalities like MRI and CT scans.
  • The aforementioned pointers are expected to fuel the adoption of titanium implants in the thoracolumbar spinal fusion procedures.
     

Based on surgery type, the Southeast Asia market is segmented into open surgery and minimally invasive surgery. The minimally invasive surgery segment is expected to record higher growth with a CAGR of 5.7% over the analysis period.
 

  • The thoracolumbar spinal fusion implant market is expected to register robust growth driven by the rising adoption of minimally invasive surgery (MIS), where the technique has the ability to preserve soft tissue, reduce blood loss, and shorten both hospital stay and overall recovery time. As a result, surgeons increasingly turn to MIS when addressing trauma, degenerative-disc disease, and a range of other spinal deformities.
     
  • Additionally, the recent upgrades in navigation tools, tubular retractors, and percutaneous pedicle-screw kits have boosted both safety and repeatability.
     
  • Further, patient demand for less invasive surgery, coupled with the growing practice of performing spinal procedures in outpatient surgical centers, is speeding the shift. Further, owing to added robotic assistance and live imaging, MIS clearly emerges as a high-growth arena in spinal-fusion care.
     

Based on indication, the Southeast Asia thoracolumbar spinal fusion implants market is categorized into degenerative disc disease, spinal trauma, spinal deformities, spinal tumors, and other indications. The degenerative disc disease segment accounted for leading share in the market in 2024 and was valued at USD 31.3 million.
 

  • Thoracolumbar spinal devices such as pedicle screws, interbody cages and rods are well-suited to stabilize and restore disc height, making them the preferred choice in procedures related to degenerative disc disease (DDD).
     
  • Favorable reimbursement schemes coupled with growing public and private spending on medical devices have contributed to increased spinal fusion procedures for people with degenerative disc disease.
     
  • Degenerative disc disease is considerably prevalent among aging and sedentary populations and represents the most common source of back pain worldwide. Thus, the large symptom-driven patient base propels demand for effective, long-term surgical solutions.
     
  • Moreover, the rising number of DDD cases, combined with new thoracolumbar implants, advance surgical instruments, and favorable institutional backing, further propels the segmental progression.

 

Southeast Asia Thoracolumbar Spinal Fusion Implants Market, By End Use (2024)

Based on end use, the Southeast Asia thoracolumbar spinal fusion implants market is classified into hospitals, ambulatory surgical center, and orthopedic clinics. In 2024, the hospitals segment held highest market share and is expected to showcase significant growth over the analysis period.
 

  • Hospitals act as the front line healthcare settings for patients suffering with traumatic injuries, tumorous growth, and other structural deformities of the spine, and thoracolumbar fusion is among the necessary treatment for such indications.
     
  • These facilities have the capabilities to perform complex and multilevel fusion procedures. Such healthcare settings generally house state-of-the-art imaging, robotic platforms, and real-time navigational tools, all of which allow surgeons to position implants with exceptional accuracy to enhance overall surgical results.
     
  • Moreover, an integrated group of senior orthopedic and neurosurgeons, supported by comprehensive intensive-care resources, establishes the hospital as the preferred location for both planned and emergency spinal surgeries. Growing surgical volumes, expansion and adoption of robot-assisted techniques, enable these settings to remain well prepared to fulfill the continuous need for a range of orthopedic procedures.

 

Thailand Thoracolumbar Spinal Fusion Implants Market, 2021 – 2034 (USD Million)

The Thailand thoracolumbar spinal fusion implants market was valued at USD 17.1 million and USD 17.7 million in 2021 and 2022, respectively. The market size reached USD 19 million in 2024, growing from USD 18.3 million in 2023.
 

  • Private hospitals in Thailand remain the key growth driver as they deliver better treatments including surgery, minimally invasive techniques, incorporating advanced tools.
     
  • Leading spinal hospitals, especially the private facilities in the country, are quick on adopting and integrating new tools such as intraoperative navigation, robotic assistance, and expandable cages, all of which depend on precise and durable implants.
     
  • In addition, budgetary pressures on public-health systems encourage hospitals to use implants that are durable, cost-effective and deliver long-term value, reinforcing a positive outlook for the market.
     
  • Further, factors such as the growth of minimally invasive approaches and the increased surgical volume due to high road fatality cases in Thailand further strengthens the product demand.
     

Singapore thoracolumbar spinal fusion implants market accounted for significant revenue share and was valued at USD 16.1 million in 2024 and is anticipated to show notable growth over the forecast period.
 

  • Growing awareness of back problems and better access to imaging allows doctors to diagnose conditions earlier and recommend necessary treatments including surgery. Singapore along with other regional countries are investing considerably into robotic and minimally invasive spinal platforms.
     
  • In addition, the thriving medical tourism in the country attracts patients seeking cost-effective, high-quality implants, thus pushing the product demand and improving the market’s overall footprint.
     
  • Finally, growing spine-focused courses and community workshops are sharpening surgeons’ skills in challenging thoracolumbar cases thus adding further momentum to the market.
     

Southeast Asia Thoracolumbar Spinal Fusion Implants Market Share

The market is dominated by some of the major market players. The market is highly competitive in nature, with major organizations, small local players, and start-ups joining the industry competition. Leading companies, such as Globus Medical, DOUBLE MEDICAL, DePuy Synthes (JnJ), GS Medical, Medtronic, and Stryker (VB Spine) maintain a strong presence with extensive product portfolios of thoracolumbar spinal fusion implants.
 

Additionally, the industry players have a keen focus on R&D and are offering innovative solutions for thoracolumbar spinal fusion implants. These players have implemented expansion strategies such as mergers, product development and launches to increase their market presence and enter new untapped markets.
 

Southeast Asia Thoracolumbar Spinal Fusion Implants Market Companies

Few of the prominent players operating in the Southeast Asia thoracolumbar spinal fusion implants industry include:

  • Alphatec Spine
  • B. Braun
  • DePuy Synthes (JnJ)
  • DOUBLE MEDICAL
  • Globus Medical
  • GS Medical
  • Highridge Medical (ZimVie)
  • Medtronic
  • Orthofix Medical
  • Spineart
  • Stryker (VB Spine)
  • WASTON MEDICAL
     
  • Medtronic is among the leading innovators in spinal surgery, offering a wide thoracolumbar fusion implant portfolio that features expandable inter-body cages and sophisticated pedicle screw sets. The firm also prioritizes minimally invasive techniques and a worldwide footprint through acquisition of smaller industry players.
     
  • Highridge Medical is a specialized spinal implant manufacturer known for delivering cost-effective, OEM-focused thoracolumbar fusion solutions. The company focuses on offering custom solutions to end users with different spine related deformities and conditions.
     

Southeast Asia Thoracolumbar Spinal Fusion Implants Industry News

  • In February 2025, Globus Medical introduced the HILINE Fixation System, an advanced posterior band fixation solution tailored for cervical and thoracolumbar spine applications. Engineered with robust implants and streamlined instrumentation, HILINE enhances deformity correction, stabilization in compromised anatomy, and ligament augmentation. This launch strengthens the company’s position in the Southeast thoracolumbar spinal fusion implants market.
     
  • In October 2022, Orthofix and SeaSpine completed their earlier announced merger, forming a leading global spine and orthopedics company with a strengthened portfolio of biologics, navigation-enabled hardware, and advanced interbody fusion devices. This development may enable the company to enhance its product range and improve the sales prospects.
     

The Southeast Asia thoracolumbar spinal fusion implants market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Product Type

  • Pedicle screws
  • Intervertebral body fusion device (IBFD)
  • Rods
  • Plates
  • Other product types

Market, By Material

  • Titanium
  • Polyether-ether-ketone (PEEK)
  • Cobalt chrome
  • Stainless steel
  • Other materials

Market, By Surgery Type

  • Open surgery
  • Minimally invasive surgery

Market, By Indication

  • Degenerative disc disease
  • Spinal trauma
  • Spinal deformities
  • Spinal tumors
  • Other indications

Market, By End Use

  • Hospitals
  • Ambulatory surgical centers
  • Orthopedic clinics

The above information is provided for the following countries:

  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Vietnam
  • Philippines
  • Rest of SEA
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are the major companies operating in the thoracolumbar spinal fusion implants industry in Southeast Asia?
Key players include Medtronic, DePuy Synthes, Globus Medical, Stryker (VB Spine), DOUBLE MEDICAL, and GS Medical.
What role do hospitals play in the Southeast Asia thoracolumbar spinal fusion implants market?
Hospitals held the largest share in 2024, serving as the main hub for complex fusion surgeries. Their integration of advanced imaging systems, robotic tools, and specialized surgical staff has driven adoption across the region.
Which surgical method is expected to grow faster in the thoracolumbar spinal fusion implants market?
The minimally invasive surgery segment is expected to grow at a CAGR of 5.7% from 2025 to 2034, fueled by shorter recovery time, reduced blood loss, and increased patient preference for outpatient procedures.
Which country in Southeast Asia generated the highest revenue in thoracolumbar spinal fusion implants in 2024?
Thailand led the market with USD 19 million in revenue in 2024, followed closely by Singapore at USD 16.1 million, driven by medical tourism, advanced surgical capabilities, and adoption of robotic-assisted techniques.
How much revenue did the degenerative disc disease segment generate in 2024?
Degenerative disc disease was the leading indication segment and contributed USD 31.3 million in revenue in 2024, supported by a high prevalence among aging populations in countries like Thailand and Vietnam.
What was the value of the titanium implants segment in the Southeast Asia market in 2024 and how will it grow by 2034?
Titanium-based thoracolumbar implants gained strong traction in 2024 and are expected to reach USD 38.3 million by 2034, benefiting from their strength, biocompatibility, and compatibility with imaging modalities like MRI and CT.
Which product segment led the thoracolumbar spinal fusion implants market in 2024?
Pedicle screws led the market with a value of USD 24.8 million in 2024, due to their critical role in providing three-dimensional stability in spinal fusion surgeries, especially for trauma and degenerative conditions.
What was the market size of thoracolumbar spinal fusion implants in Southeast Asia in 2024?
The Southeast Asia thoracolumbar spinal fusion implants market was valued at USD 61 million in 2024, driven by rising spinal disease prevalence, trauma injuries, and a growing shift toward minimally invasive spinal procedures.
How much is the Southeast Asia thoracolumbar spinal fusion implants market expected to reach by 2034?
The market is projected to grow to USD 93.4 million by 2034, expanding at a CAGR of 4.4% from 2025 to 2034 due to technological innovations, improved implant materials, and the region’s medical tourism growth.
What is the market value of thoracolumbar spinal fusion implants in Southeast Asia in 2025?
The market is expected to reach USD 63.4 million in 2025, reflecting steady demand from hospitals and ambulatory surgical centers across Thailand, Singapore, and Vietnam.
Southeast Asia (SEA) Thoracolumbar Spinal Fusion Implants Market Scope
  • Southeast Asia (SEA) Thoracolumbar Spinal Fusion Implants Market Size
  • Southeast Asia (SEA) Thoracolumbar Spinal Fusion Implants Market Trends
  • Southeast Asia (SEA) Thoracolumbar Spinal Fusion Implants Market Analysis
  • Southeast Asia (SEA) Thoracolumbar Spinal Fusion Implants Market Share
Authors: Mariam Faizullabhoy, Gauri Wani
Trust Factor 1
Trust Factor 2
Trust Factor 1
Premium Report Details

Base Year: 2024

Companies covered: 12

Tables & Figures: 70

Countries covered: 7

Pages: 120

Download Free PDF

Top
We use cookies to enhance user experience. (Privacy Policy)